CDMO News
Huons Invests 14.3 Billion Won to Acquire Majority Stake in PanGen Biotech
Huons, a Korean healthcare company, announced today its acquisition of a 31.5% stake in PanGen Biotech, representing a strategic 14.3 billion won investment. This move will establish Huons as the largest shareholder in PanGen, enabling it to expand into the
6 November 2024
Stay ahead of trends and best practices
